Crossing the Immunological Barrier by Qazi, Farrah
1Crossing the Immunological Barrier
A man sits shaking on an airplane. Sweat soaks his face, his arms and legs shake 
uncontrollably. Within hours of landing in California, the man lies dead, and hundreds of 
people are infected with the same mysterious virus.  In another scenario, a teenage boy 
unknowingly sells drugs laced with a deadly viral strain. Terrorists threaten to release the 
virus to the nation, causing the entire population to be eradicated within days.
 These are the respective premises of the movie Outbreak and the television show, 
24. Hollywood has always been fascinated by such apocalyptic themes. Biological 
weapons and viruses are prevalent instruments used to create movies and shows that depict 
chaos and mass destruction. Until September 11, 2001, the majority of people viewed these
depictions as highly exaggerated dramas. However, when the towers crumbled in New 
York City, the public was faced with a frightening possibility.
News shows, magazines, and even the U.S. President, made dire predictions about
biological threats to national security.  Most of the viruses that the government worried 
about were animal disease strains. Anthrax, SARS, Monkey pox, West Nile virus… the list 
goes on and on. But what is the likelihood of these diseases causing widespread illness and 
deaths? This is the question experts are faced with today. This is also the inspiration for 
writing this article.  
The questions surrounding animal importation and diseases are varied and 
complex. In fact, Hollywood’s portrayal of the problem is only one minor element of the 
issue. This article is divided into four sections. First, the article provides a brief 
background of problem. Second, the article discusses xenotransplantation and its risk of 
2spreading diseases. Third, international trade laws are discussed in light of public health
concerns. Lastly, the article summarizes the findings of this article and introduces possible 
prevention and control strategies.
Part One: Background of Zoonotic Diseases
“Zoonoses” is the term used to describe the transmission of animal disease to 
humans through either airborne or physical contact.1 The dangers of zoonoses are 
numerous. Often, the diseases that animals carry are latent and harmless while residing in 
their bodies. However, once they are transmitted to humans, they may mutate into 
dangerous or even deadly illnesses. Since animals carry pathogens that humans do not 
possess, human immune systems are not well-equipped to deal with the onslaught of new, 
foreign diseases. 2 For example, Macaque herpes is harmless to Macaque monkeys, but 
lethal to human beings.3 Similarly, Ebola outbreaks in Sudan, Zaire and the U.S. have been
linked to crossing the animal to human immunological barriers. 4 Most recently, the world 
watched as the latest evidence of cross-barrier viruses proved deadly when Europeans 
digested meat infected with Foot and Mouth Disease (FMD).5
FMD is an extremely virulent disease because it can flourish in almost any 
condition. 6FMD can be transmitted via saliva, feces, mucus, milk, tissue, urine, blood or 
air. Unlike mad cow disease, with which it is most often confused, FMD is usually 
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3harmless and rare among humans. Nevertheless, its impact upon world politics was felt in 
February 2001, when the first case was confirmed in the England. Soon after, exports on 
all live animals, meat and dairy products were banned. Farmers across the continent began 
the mass slaughter of infected animals, and crops were burned to prevent further outbreaks. 
So while FMD is not as physically damaging to humans as BSE, the consequences of the 
disease are still severe.
BSE is a prion disease discovered and documented by Nobel Laureate Stanley 
Prusiner.7 Prion cells are present in all vertebrates, but in BSE, they mutate and slowly 
erode brain cells. BSE is a degenerative neurological disorder that is common in bovine.8
Since its origin is unknown, it was initially difficult to recognize the disease during the 
first ten years of its outbreak. It was not until Europeans began to die tragically in 2001 
that the world learned of mad cow disease. BSE's human form is Creutzfeld-Jakob disease 
(CJD).9 CJD has caused ninety-four human deaths in Europe in recent years.10  This 
occurred when humans ate meat from cows that were infected with BSE.11 Humans 
infected with CJD suffer from loss of memory, tremors, hallucinations, weakness, and 
eventually cannot talk or walk.  There is no known cure for the disease. 
At the moment, BSE is considered to be a European problem, since t here are no 
known cases in the United States. This is mainly due to the United States’ quick prevention 
strategies. Soon after the outbreak was confirmed to be linked to meat, the United States 
banned its importation. Nevertheless, the possibility that such a disease could permeate our 
borders has raised several concerns about the efficacy of food and animal centers.
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4Bovine diseases are only one type of zoonoses. Other illnesses include West Nile 
Virus, dengue fever, anthrax and SARS. Since these are all infectious diseases, they are 
often classified as emerging infectious disease or EID. Examples of EID include typhoid, 
smallpox and malaria. These diseases are better documented and recognizable than 
zoonotic diseases because their existence dates to early existence. Thus, zoonoses poses a 
greater problem than regular infectious diseases because it is still an uncharted territory. As 
new diseases emerge, scientists work hastily to discover their origins, symptoms and how 
to contain them. In the meantime, the EID infects and spreads unhindered. Most 
importantly, zoonotic diseases pass human immune systems and take root within the 
human body. In most instances, this permeation occurs unintentionally through physical or 
airborne contact. However, in the case of xenotransplantation, permeation may occur 
willfully when patients subject themselves to this procedure. 
Part Two: The Interesting Problem of Xenotransplantation
1. Background
Xenotransplantation is an innovative medical procedure in which tissues, organs,  
body fluids and cells from animals are transplanted into humans.12 Xenotransplants 
perform the same functions as the human materials they replace. The procedure is intended 
as a solution to the shortage of human organs (allotransplants).13 End-stage organ failure is 
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5the most critical health problem facing Americans today.14 Currently, more than 65,000 
people are on the national organ transplant waiting list.15 Approximately 4,000 of them die 
annually while waiting for a suitable organ transplant.16
Heart failure cases provide another potent example of the insufficient supply of 
organ transplants. Heart failure kills four times more people than HIV infection.17 The 
most effective remedy to heart failure is transplantation.  Unfortunately, the demand for 
organ donations far exceeds its supply. It is estimated that only 2,000 human hearts are 
available annually for approximately 45,000 patients who could use them.18 Given these 
statistics, it is little wonder that scientists have tried to devise alternatives to human organ 
donations. The most popular choice has been to turn to animals for organ donations. 
2. History
Cross-species transplantation dates back to the early twentieth century, when
kidney xenografts of rabbit, pig, goat, primate and lamb donors were used.19 After a series 
of fatal procedures, however, scientists did not attempt further procedures until the 1950s. 
In 1954, Drs. Murray, Harrison and Merrill performed the first successful human kidney 
transplant between identical twins at the Brigham Hospital in Boston Massachusetts.20
Twenty years later, the first successful heart transplant followed suit.21 Unfortunately, the 
lives of these recipients were often not extended beyond a few days. In fact, the longest 
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6survivor at that time was a newborn baby with hypoplastic left heart syndrome. “Baby 
Fae” received a mismatched ABO-blood group baboon heart that only functioned for 20 
days.22
Initially, primates were the chosen donors because they are the most similar species 
to human beings. 23Scientists hoped their anatomical structures would be so compatible 
that immune rejection would not occur. However, these attempts were largely 
unsuccessful.24 Their failure was due to the fact that primates do not have Type O blood 
types (the universal donor) and cannot be bred in large colonies.25 Additionally, numerous 
animal rights organizations decried the practice. They claimed it exploited animals that had 
similar structures, feelings and thought processes of human beings.
3. Using Pigs as Donors
Undeterred, scientists then looked to pigs for potential donorship. Pigs, particularly 
miniature swine, are most desirable because their organs are similar in size and anatomy to 
humans.26 Additionally, they are abundant and generally accepted as a source of food, 
clothing and goods.27 Therefore, the use of pigs does not garner the same level of 
controversy that primates do. In fact, the Nuffield Bioethics Committee concluded in its 
second report that using pigs was ethical while using primates was not. 28
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7However, the main obstacle with using pigs as donors for xenotransplantation is 
that all pigs are born with two copies of a gene that create a sugar molecule that attaches to
cell surfaces.29 This molecule, called alpha-1-galactose, is very similar to a bacterial sugar. 
Thus, when a pig organ is inserted into a human body, the human immune system releases 
antibodies to aggressively fight the foreign substance. This inevitably leads to rejection of 
the organ within a matter of minutes. 30
In response to this problem, scientists have genetically altered pig organs to 
become more compatible with humans. In February 2003, a Wisconsin biotech firm, 
Infigen, claimed it had genetically engineered and cloned a litter of three miniature swine 
in which both copies of the gene that creates alpha-1-galactose-have been suppressed.31
This recent development has major repercussions. Like the cloning of Dolly the sheep, it 
allows for the creation of more genetically engineered creatures. By creating pigs that can 
theoretically be transplanted into humans without being rejected, Infigen has leapt forward 
into a new age of transplantation. The consequences of this discovery are numerous. With 
them come increased responsibilities and legal concerns. 
4. The procedure
The first step in the process of xenotransplantation is to find a suitable animal 
donor.  Just as in allotransplantation (the procedure of transplanting organs from one 
human to another), recipients receive drugs after the transplant to reduce the risk of 
immune rejection.  Unfortunately, the use of immunosuppression drugs makes the recipient 
29 Id.
30
 John Fauber, Cloned piglets may be successful in human transplants, firm says. The Milwaukee Journal 
Sentinel, February 28, 2003. 
31 Id at *1.
8more susceptible to ordinary diseases. Usually, when an organ is transplanted, some level 
of rejection occurs despite the compatibility of the match.  The use of non-human organs 
heightens the risk of such rejection. It also elevates the need for immonsupression drugs,
which increases the recipient’s chances of infection and illness. “[T]transplanting a non-
human primate organ into a human recipient will require a greater level of 
immunosuppression in the recipient than the same procedure involving a human organ; and 
a pig organ will involve an even greater level of immunosuppression in the recipient than 
the organ from the non-human primate”.32
Furthermore, the traditional barriers of skin, immune systems and gastrointestinal 
tracts that protect humans from the spread of infections are circumvented when 
xenotransplantation takes place. Thus, animal diseases are essentially imbedded into the 
natural make-up of a human being.  Since pigs are vastly different than humans, the cross-
species barrier that is being circumvented is so wide that the potential for diseases is 
greater.33 One of the greatest risks to xenotransplantation with pig organs is that a pig virus 
may infect the human recipient and mutate. 34 The most potent virus that swine carry is 
porcine endogenous retroviruses (PERV). PERV belongs to the same family of 
retroviruses that cause AIDS. 35 Unlike other viruses that can be eliminated through 
breeding or raising pigs in a sterile environment, PERV is imbedded into the typical 
genetic makeup of pigs. Therefore, it is hereditary and cannot be suppressed like the gene 
that creates alpha-1-galactose. 36
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9The disease is even more dangerous because it is difficult to quantify the risks it 
poses to humans. Since no solid pig organ has yet been transplanted into a human, it is 
impossible to ascertain exactly what risks human may encounter. By the same token, it is 
also impossible to develop drugs or safeguards against such potential risks. In a worst case 
scenario, if solid pig organs are transplanted without safeguards, PERV and other diseases 
could not only infect the recipient’s immune system but also all friends, family members, 
and others s/he may come in contact with.37
Even if the strictest safeguards are enforced, xenobiotechnology will always carry
the risk of introducing and spreading zoonotic diseases. Besides PERV, pigs are known to 
have at least 25 diseases that can be transmitted to humans.38 For instance, the deadly 
human influenza virus in 1918 that killed approximately 20 million people worldwide was 
a mutation of a swine flue virus. 39 Most recently, the "Nipah" virus, discovered in 
Malaysia in late 1998, spread from pigs to hundreds of humans.40 This led to the mass 
slaughter of some one million pigs, as well as several dogs and horses. 
Although many critics argue most claims about possible xenotransplant outbreaks 
are unsubstantiated, some facts are undisputed. Scientists know viruses can infect one 
organism while passing to another. They also know a virus that is harmless in one species 
may be lethal in another. HIV, the human immunodeficiency virus, is one example of this 
risk.41 Many researchers believe HIV originated from primates.42  These scientists believe 
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HIV is a simian immunodeficiency virus(SIV) that crossed the species barrier in Africa.43
If this is true, primates have never suffered the devastating effects of HIV that humans 
have. So HIV, like other cross-species viruses, is more dangerous in humans than in its 
original animal hosts. Similarly, monkey pox, Ebola and other viruses are prevalent among 
monkeys.44 When they passed to human beings, though, the consequences have been 
terrible. 
Dozens of such infections have been documented in journal articles of the last 
decade. The major problem with zoonoses is that it creates unforeseeable health risks for 
both the recipients and the general public. The basic structure of these diseases lends itself 
to mass outbreaks. Since the diseases are often latent and highly contagious, it is easy for 
an infected individual to spread the disease to family, friends and community members. 
Also, the fact the procedure is so new makes it is difficult to evaluate exactly how great 
this risk is. 
5. Prevention and Control
These sobering facts have led this author to conclude t hat xenotransplantation
undermines any real efforts to control infectious diseases. With the increased awareness of 
animal diseases, the potential for outbreaks has become a very serious possibility. Thus, 
the need for legally viable safeguards against these dangers is substantial. In order to 
minimize the possibility of more outbreaks, the federal government must increase its 
regulation of xenotransplantation.
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In 1996, the Centers for Disease Control (CDC), the Food and Drug Administration 
(FDA)  and the Department of Health and Human Services (DHHS) published a set of 
guidelines for xenotransplantation.45 It suggested all xenotransplantation procedures should 
be regulated under new FDA investigational new drug regulations and informed consent 
laws.46 However, the FDA has not yet adopted these guidelines. Nonetheless, the 
guidelines are useful when trying to determine what safeguards can be placed on 
xenotransplantation.
The guidelines suggest the federal government should provide for specially 
designated teams that monitor data, tissue storage and surveillance. It also recognizes the 
need for government regulated clinical facilities, protocol reviews, informed consent 
regulations and the maint enance of animal donor populations. 47 Such prevention strategies 
are an important step, but pose several legal and ethical dilemmas.
a. Surveillance 
Most commentators agree that any attempt to control the spread of infectious 
disease requires a surveillance system. However, it is important to recognize such a system 
would not prevent the spread of disease on its own. Due to the nature of these diseases, 
many infections can spread, undetected, even under the most rigorous surveillance system. 
Furthermore, a system designed to monitor the progress and movement of individual 
recipients could clash with basic fundamental rights. For example, the rights to travel, 
movement and privacy would necessarily be infringed by such a system. These rights have 
been historically recognized and honored by the U.S judicial system. 
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 In Apetheker v. Secretary of State, for example, the U.S. Supreme Court held the 
right to travel was a fundamental right protected by the due process clause of the 5th
Amendment.48 It further stated: “freedom of movement across frontiers in either direction, 
and inside frontiers as well, was a part of our heritage. Travel abroad, like travel within the 
country, may be as close to the heart.as the choice [] to eat, wear or reads”.49 On the other 
hand, Zemel v. Rusk recognized the government’s right to restrict some travel when flood, 
pestilence or other natural disasters threaten public safety.50 Therefore, when the risks of a 
disease are obvious, the government should be allowed to limit an individual’s 1st
Amendment and due process rights. However, the true dilemma occurs when the risks of a 
disease are speculative. In these cases, the government cannot justify its actions without 
ample proof of its necessity. This is the dilemma xenotransplantation poses. This also 
explains the FDA’s current reluctance to impose a surveillance program that may infringe 
upon these rights. Until further research is conducted, it is difficult for the government to 
implement preventive programs that will honor case precedent. 
In recognition of the need to impose public safety measures, the United Kingdom 
has adopted guidelines for a surveillance system that can serve as a model for the United 
States.51 The UK proposal enables quick detection, management and investigation of 
possible infectious diseases emerging from xenotransplantation. It requires recipients to 
agree to: (a) regular samples of bodily fluids that are then tested for disease; (b) refrain 
from donating blood, organs or tissues; (c) register their name and address on a national 
registry at all times; (d)post-mortem analysis; and (e) divulge all confidential information 
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to health care officials.52 Theoretically, such a model could help stop the spread of 
infectious animal diseases. However, can any government really sustain such an extensive 
program? Considering the procedural and monetary logistics involved, one has to ask 
whether such a system would place an undue burden upon individuals and the government. 
Also, how can such a proposal be reconciled with constitutionally guaranteed rights? 
2. Informed Consent
Proponents of xenotransplantation argue the balance between protecting individual 
constitutional rights and the duty to maintain public health can be achieved through 
comprehensive informed consent procedures. . Even a cursory look at health law cases 
would illustrate, however, that informed consent is not such a simple alternative. Informed 
consent in other areas of health law, such as drug testing, abortion and clinical trials, has 
often resulted in complex and protracted litigation. This is partly due to the vulnerability of 
patients who purport to give their informed consent. As sick and desperate individuals, 
many patients do not possess the sound mind or body to give their consent . A patient’s 
debilitated condition exposes his/her susceptibility and vulnerability. Often the patient’s
desire to recover from the disease clouds any rational judgment. In short, a patient who is 
dying from organ failure and suffering from excruciating pain may consent to almost 
anything to recover from his/her fate. Under such circumstances, can any informed consent
be legitimate?
Furthermore, informed consent laws work best with known diseases that can 
predict known outcomes. In such cases, physicians can thoroughly explain a diagnosis and 
the patient’s options. The patient can then research and weigh those options intelligently. 
52 Id.
14
In the case of xenotransplantation, however, this is not possible. A patient essentially 
would place his/her life in the hands of a scientist who also cannot assess the risks 
associated with the procedure. First, there is no conclusive scientific data about the side 
effects of xenotransplantation. Even its success at prolonging one’s life is not guaranteed. 
Second, its impact upon public health has not yet been ascertained. Therefore, a patient 
may be subjected to regular tests, scrutiny and surveillance without fully understanding the 
associated consequences. 
Patients’ Rights
The informed consent doctrine is premised on the patient’s right to know and the 
right to self-determination. In the instance of xenotransplantation, both rights are infringed. 
First, a physician has a duty to inform the patient of the nature of a proposed procedure, its 
nature and risks. Second, a patient has the right to accept or forgo treatment after reviewing 
the information. As stated earlier, this process cannot occur with xenotransplantation. 
Unless more is learned about this clinical procedure, it is impossible to gain informed 
consent.
Nuremburg Code
The notion of informed consent was developed after World War II, when the world 
learned that Nazis had performed experimental medical procedures on unwitting prisoners. 
During the Nuremburg trials in December 1946, sixteen German defendants were 
prosecuted for war crimes and crimes against humanity during the Nazi reign and 
convicted by an American court. The greatest legacy of those trials was the creation of the 
15
Nuremberg Code, a set of ten principles laid out by the judges who decided the case. 53The 
Nuremberg Code is significant worldwide because it directly limits the purpose and effects 
of human experimentation. After the horrors of unregulated medical experimentation were 
revealed, the Western nations agreed that such a Code was vital to preventing further 
cruelty against human beings. 
The first principle of the Nuremberg Code asserts “the voluntary consent of human 
subjects is absolutely critical”. 54For the aforementioned reasons, this tenet of the Code is 
violated by the advent of xenotransplantation clinical trials. Informed consent cannot be 
achieved in such a volatile environment. Given the experimental nature of the procedure, 
the risk of preying on vulnerable patients is great. Xenotransplantation may give patients 
false hope about their recovery. This pretense may propel patients to consent to procedures 
they normally would not agree to. Also, insufficient date prevents physicians from fully 
explaining the risks of consequences. As a result, informed consent cannot be achieved.
Additionally, xenotransplantation violates the second Nuremberg principle. That 
principle states any experiment should “yield fruitful results for the good of society”.55 As 
explained, transplanting pig (and other animal) organs into human beings erodes the 
natural barrier between human and animal species. Thus, disease and infection are given 
full reign of the human immune system. The consequences of this transplantation are 
enormous since the diseases that humans may acquire are highly dangerous and 
contagious. Thus, recipients, their families, friends and society are put at risk when 
xenotransplantation takes place. 
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Each of the Nuremberg Code principles is nullified by the participation of humans 
in the xenotransplant clinical trials. Nowadays, the Nuremberg Code is not used as decisive 
legal authority. Nevertheless, it serves as a guidepost for national regulations on 
experimental procedures. Critics argue the Code, and its principles, restrict the 
advancement of biotechnology. Scientists feel particularly constricted by the first and 
second principles of the Nuremberg Code. Experimental procedures are always uncertain 
explorations into unknown realms. Thus, they argue adherence to these principles hinders 
their development. 
Nevertheless, the Nazi experiments and the recent Tuskegee controversy should 
demonstrate the need to abide by the Nuremberg principles.56 In order to maintain human 
dignity and integrity, it is vital that world governments adopt some semblance of the 
Nuremberg Code in their supervision of experimental procedures. 
b. Third Party Consent
Even if patients are able to give their informed consent, it would be impossible to 
obtain consent from all third parties involved.  A xenograft recipient not only places 
himself in danger of infection, but all those s/he comes in contact with as well. Thus, by 
the definitions of human rights laws, every third party who may be exposed to an 
infectious disease must consent to such a risk.57 Otherwise, an unconsented exposure to 
health risks would violate the tenets of the Nuremberg Code, the 1964 U.N. Helsinki
Declaration and other declarations.
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c. Temporary Solution
Given these problems, a moratorium must be placed on xenotransplantation
procedures until the risks of infectious disease can be assessed and controlled. Without 
such a moratorium, the government places its citizens at risk of contracting dangerous 
infectious diseases. While the benefits of xenotransplantation are clearly recognizable, the 
risks of such a procedure are too great to proceed. Nonetheless, the issue of 
xenotransplanta tion is just one facet of the problem of animal infectious diseases. 
Part Three: International Trade Laws
1. Public Health, Economy and Migration
While a discussion of xenotransplantation is mostly hypothetical at this stage, the 
global impact of animal infectious diseases is documented proof of the need for control 
and prevention. As stated, disease outbreaks can have far-reaching consequences on global 
trade and economy. When a disease like mad-cow disease infects the human population, 
prices in food, medicine and stocks plummet. Other areas of public health are also affected. 
For example, when FMD infected the meat in Europe, surgical centers in New York
suffered.58 Since that outbreak, surgical centers couldn’t receive blood donations from 
Europe so their blood supply has seriously diminished.  59 Additionally, when FMD 
outbreaks ravaged European countries, the United States Department of Agriculture placed 
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a ban on all live animal and meat imports. This widespread ban resulted in an economic 
loss of $250 million.60
The USDA, CDC, the National Institute of Health (NIH) and the FDA, work 
together to protect Americans from diseases associated with animals. Although the 
aforementioned disease pose significant threats to a person’s well-being, other diseases are 
dangerous economically. For example, FMD is economically disastrous for 
underdeveloped nations. Since a FMD vaccine is available, many countries can implement 
extensive vaccination programs for their livestock. However, such a program can cost 
billions of dollars. Therefore, it is almost impossible for developing countries to employ.  
However, if these countries decide not to vaccinate its animal population, it faces 
embargos from other countries and a loss of its entire trade supply.61
2. NAFTA and GATT
International trade with the United States is governed by both NAFTA (North 
American Free Trade Agreement) and GATT (General Agreement on Tariffs and Trade). 
With the adoption of these treaties, the trade of livestock and livestock products among 
member nations has grown.62 The main concern with this increase is that animal diseases 
will spread faster and wider as a result. Since the implementation of NAFTA and GATT 
naturally heighten the risk of animal importation disease, this article must explore these 
treaties. 
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During the Tokyo round of GATT negotiations in the 1970s, member nations 
agreed to devise a “Standards Code” that would help nations adopt international standards 
to suit their needs.63 The result of the conference was two agreements which are in 
existence today. The Agreement on Technical Barriers to Trade (“TBT”) requires that 
regulations have a legitimate objective that is not “trade restrictive”. SPMS (Sanitary and 
Phytosanitary Measures) instructs members to protect human or animal life from the 
spread of disease.64 Nations, including the United States, use SPMS as justification for 
laws they impose against certain animals or products. 
Both treaties contain provisions about SPMS that could potentially affect the 
migration of animals from one country to another.  SPMS measures are defined as any 
measure applied to “protect animal or plant life or health within the territory of the 
Member from risks…”65 All SPMS measures must be based on scientific evidence that 
supports the level of protection the Member chooses.66 However, these stricter “scientific 
requirements” are not always met when the US imposes embargos on particular animals or 
by-products.
Risk Assessment and Scientific Requirement
 NAFTA and GATT allow Member states to determine their own levels of 
protection from public health risks. However, this level must be justified by sound 
scientific evidence that the risk is viable and imminent. The levels of protection must also 
be based on “risk assessment”. This means Members must evaluate the likelihood of entry 
63
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and the spread of disease.67 Such a test was intended to prevent one country from unfairly 
placing embargoes upon another. In the spirit of free trade and democracy, the treaties 
hoped to eradicate prejudices and politics from the arena of international trade. In light of 
animal importation and diseases, however, the requirements for scientific evidence can be 
problematic. For those Members concerned about adhering to NAFTA and GATT, bans 
on foreign animals and substances can only be placed after extensive scientific evidence is 
gathered, documented and approved. Naturally, this poses a dilemma for a country faced 
with an emergency situation. 
If a country is faced with an epidemic arising from xenotransplantation for 
example, it may be very difficult to obtain the requisite scientific evidence. Since such an 
epidemic has never occurred before, scientists would be hard pressed to speculate about the 
likelihood of its entry/departure into the country or its spread. Thus, by the definitions of 
NAFTA and GATT, the United States would not be justified in imposing a ban on travel or 
trade. So while the United States tries to sort out these logistics, infected persons or 
animals could move freely between countries, infecting others in their wakes. What 
international trade laws seem to ignore is most animal diseases insidiously creep into a 
human’s immune system without timely detection. Thus, it is tremendously challenging for 
a Member to provide a “scientific requirement” every time it plans to contain a disease. 
The test posed by NAFTA and GATT illustrates the difficulty nations face when they 
balance their duty to protect their citizens while simultaneously obeying international trade 
agreements. 
Furthermore, debates arise over whether such stringent scientific requirements are 
even necessary or prudent in this modern time of communicable diseases, increased travel 
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and bioterrorism. Some critics of SPMS and other international laws believe scientific 
requirements actually endanger public welfare. For example, if a country receives a 
potential threat of an animal bearing a deadly disease, such as anthrax, it must first undergo 
a series of serious tests to prove such a threat is viable and imminent. Under the WTO, a 
member state must first prove the risks are scientifically approved.   
While authorities undergo such tests, critics argue, the animal may continue to be 
imported into the US while a country tries to justify its ban. Such requirements may prove 
to be very costly to a country that is constantly deluged with imports. If each potentially 
harmful item must be a lengthy inspection before being banned from importation, the law 
may defeat its intended purpose.  This article recognizes the need for scientific 
requirements to prevent discrimination among foreign suppliers. However, it proposes that 
this test must be considered within an international context.68
It is important to note that a regulation that restricts foreign trade in order to protect
public health and welfare is generally given some level of discretion. The Appellate Bodies 
of most countries have respected the rights of member nations to determine their own risk 
levels.69  Nonetheless, this risk assessment test forces Members to identify the disease and 
its consequences and prove its likelihood to spread via the banned product. 
Australia-Salmon Case
This test was illustrated in the Australia-Salmon case. In that instance, Australia 
had developed a successful salmon industry. As a result, it banned the importation of 
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foreign salmon claiming it would infect domestic fish with certain diseases. 70 Canada 
challenged this ban, claiming it did not meet “risk assessment, as defined by the SPMS 
Agreement. Upon reviewing the charge, the Appellate Body considered factors listed 
within the SPMS Agreement. These factors state risk assessment m ust identify the disease, 
evaluate its likelihood of entry and determine the probability of its spread according to 
certain SPMS guidelines. 71 The Appellate Body concluded Australia met the first prong of 
risk assessment because it identified the diseases associated with the importation of foreign 
salmon. Nevertheless, Australia did not meet the second prong because it could not 
describe the likelihood of the disease entering and spreading within the nation.
Consequently, the Appellate Body in the Australia-Salmon case recognized that 
any regulation prohibiting free trade of goods and services without ample scientific proof 
of its adverse health effects may be classified as a “technical barrier of trade”. These are 
domestic regulations that disadvantage or exclude foreigners from local markets.72 The 
most obvious technical barrier to trade is a ban on foreign products that discriminates 
between various suppliers.73 Facially nondiscriminatory regulations can also fall within 
this definition. For example, if a regulation requires foreign suppliers to undergo greater 
scrutiny, this may be classified as a technical barrier as well. Under this doctrine, facially 
discriminatory and nondiscriminatory regulations may have the same effect on 
international trade. Thus, the World Trade Organization has imposed obligations upon 
domestic regulations that extend beyond nondiscrimination requirements.
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3. The World Trade Organization (WTO) and Globalization
The WTO is the organization responsible for maintaining proper trade relations 
between Member nations. It was partly created to prevent such discriminatory behavior. 
Like its predecessor, GATT, the WTO intended to unify nations and equalize any 
disparities between suppliers. Essentially, the WTO forbids Members from discriminating 
against foreign suppliers.74 One way it achieves this goal is by imposing the “scientific 
requirements” test.
While imposing this restriction on its Members, however, the WTO faces a tension 
between its respect for national sovereignty and its desire to unite Members. When it was 
originally devised, the WTO was touted as a regulatory system that was respectful of the 
sovereignty of each of its Member nations. In light of the growing problem of infectious 
diseases, the WTO cannot adhere to this original notion. Any meaningful scientific 
requirement regulation must necessarily infringe upon national sovereignty. If it does not, 
then the WTO and its agreements would be rendered meaningless.  
Globalization
In order to reconcile these two duties, the WTO must redefine its concept of 
globalization. Globalization typically refers to a series of procedures that limit a state’s 
ability to control actions within its own border.75 Depending upon the status of an 
individual state, globalization can be viewed positively or negatively. For countries like the 
United States, globalization is generally a progressive step towards international 
cooperation, integration of financial markets and better foreign relations. For developing 
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countries, however, globalization can be viewed as a hindrance to national sovereignty, 
since it undermines their power over their own citizens. Moreover, unlike the United 
States, lesser nations do not have the power to challenge the WTO if a regulation does not 
suit their needs. Therefore, they are more obliged to follow global norms. 
In the public health context, globalization creates several problems. Most public 
health experts agree that traditional notions of national sovereignty cannot coincide with
the emergence of infectious diseases. 76 For example, globalization has caused historical 
borders between European countries to erode into a melting pot of Schengen states. The 
Schengen agreement enables the free travel and movement of citizens between all 
participating states. Rooted in the laudable ideas of unity and equality, the “Schengen area” 
was created when France, Germany, Belgium, Luxembourg and the Netherlands agreed to 
become a territory without internal borders in 1985.77 The "Schengen area" took its name 
from the town in Luxembourg where the first agreements were signed. In 1997, this 
intergovernmental cooperation included 13 countries. More nations are continually added. 
Adopted to create a stronger, more unified European unit, the “Schengen area” has 
been heavily criticized by traditionalists. Considered within the public health debate, the 
“Schengen Area” may provide fertile ground for infectious diseases to grow unhampered.  
Part of the Schengen agreement includes a removal of checks and inspections at common 
borders. These are now replaced by external border inspections. Consequently, travelers 
are only checked when entering and leaving the entire “Schengen Area”. This may pose a 
problem since travelers within the area move between vastly different climates and 
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conditions. Such a variety in temperatures and environments can breed more infections and 
diseases.  Thus, the “Schengen Area” is the perfect illustration of the adverse effects that 
globalization has on public health and safety.
Another example of effects of globalization is the recent Severe Acute Respiratory 
Syndrome (SARS) epidemic. SARS is a viral respiratory illness that was first reported in 
Asia in February 2003.78 Within a few months, the illness spread to more than two dozen 
countries in North America, South America, Europe, and Asia.79 Due to increased 
surveillance and stricter border inspections, the SARS outbreak was successfully 
contained. Nevertheless, the quickness of its spread should serve as a grim warning to the 
WTO and its Members of the impact of globalization in the public health context.  
Globalization has allowed dangerous pathogens to break the walls which once 
separated one nation from another. Infectious diseases have left illness and death in their 
wake. They follow no pattern and respect no borders. Now, even immunological barriers 
are eroded as cross-species diseases continue to spread. Thus, all species and nations are at 
risk of disease outbreaks. The spread of infectious diseases is no longer a problem confined 
to one nation. It must be addressed by an international community dedicated to 
maintaining the health of all persons, not just the citizens of any given country. This can 
only be achieved if the WTO, and other international organizations, make a concerted 
effort to protect public health and safety even at the expense of national sovereignty. 
Recognizing that the problem of animal diseases, and other infectious diseases, is a global 
problem is the very first step.  
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Conclusion
The issue of animal diseases touches upon several facets of health care law. Any 
discussion of zoonoses must explore the need for international cooperation and federal 
regulation of experimental trials. When discussing xenotransplantation, it is imperative that 
one recognize the risks involved in such a  procedure. Thus, every government must 
undergo a risk-benefit analysis to determine whether xenotransplantation should proceed. 
Undoubtedly, the goals of xenotransplantation are laudable. There is little question 
that the health care system is plagued by an organ donation shortage. Artificial organ 
transplants do not seem to be a viable option. Thus, animal organ donations may help fill 
this void. At no time does this article suggest that xenotransplantation cannot take place in 
the future. It only maintains that the procedure should not progress until adequate data and 
research are complied. A moratorium should be placed on xenotransplantation until the 
federal government and its state regulatory bodies have assessed all the risk involved and 
devised appropriate preventive measures. If we refuse to proceed in this cautionary 
manner, zoonotic outbreaks may be in our near future. 
Given the widespread consequences of zoonotic diseases, international cooperation 
is critical. Even if one country adopts stringent prevention and control mechanism, it can 
still be susceptible to an outbreak. This is because citizens from that country can freely 
move to other less cautious nations. Loose regulations and mechanisms can allow people 
to pick up diseases as they move from one region to another. Hence, it is highly beneficial 
that an international network is established to prevent the spread of diseases. Infectious
diseases do not discriminate between nations. They apply equally to every nation, person 
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and culture. They also affect all aspects of life. Disease outbreaks can undermine 
migration, world economy, public health and travel.  
In short, it is vital for the integrity of our global system to devise a comprehensive 
course of action against the spread of zoonotic diseases. This can only be achieved once 
the WTO and all international organizations decide to place public health concerns above 
other matters. Once these organizations realize that national sovereignty can be reconciled 
with maintaining public health, the risk of zoonotic diseases can be significantly 
diminished. 
